Johnson & Johnson's COVID-19 vaccine may be much less effective against the delta and lambda variants of the virus compared to the original strain, according to a study posted July 20 on the preprint server bioRxiv.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,